SCHEMBL31728531

SCHEMBL31728531

[2H]C([2H])([2H])Oc1cc(OCc2ncn(C(F)F)n2)c2c(N)ncnc2c1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31729146 0.83 PIK3CD (0.36) —
SCHEMBL31728916 0.81 PDE5A (0.33) —
SCHEMBL31727748 0.75 ABL1 (0.31) —
SCHEMBL31728351 0.72 SRC (0.35) —
SCHEMBL31727943 0.72 PIK3CD (0.35) —
SCHEMBL31728767 0.71 PIK3CD (0.41) —
SCHEMBL31727918 0.69 — —
SCHEMBL31727802 0.65 SRC (0.34) —
SCHEMBL31728476 0.63 PDE5A (0.35) —
SCHEMBL31729145 0.61 PDE5A (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback